22 results
424B5
NUVL
Nuvalent Inc - Ordinary Shares
17 Oct 23
Prospectus supplement for primary offering
4:05pm
to initiate, recruit, and enroll patients in and conduct and successfully complete our clinical trials at the pace that we project;
our ability to scale-up … estimates of the number of patients that we will enroll and our ability to initiate, recruit and enroll patients in and conduct and successfully complete
424B5
NUVL
Nuvalent Inc - Ordinary Shares
16 Oct 23
Prospectus supplement for primary offering
7:39am
of the number of patients that we will enroll and our ability to initiate, recruit, and enroll patients in and conduct and successfully complete our clinical … to initiate, recruit and enroll patients in and conduct and successfully complete our clinical trials at the pace that we project;
our ability to scale
424B5
gvyfwty7jp6eo77wafs
1 Nov 22
Prospectus supplement for primary offering
5:17pm
424B5
a5jslucmki1ctm3o
31 Oct 22
Prospectus supplement for primary offering
7:21am
424B5
0kbnqigmt2nfmc9 w8t
17 Aug 22
Prospectus supplement for primary offering
4:23pm
S-3
a2zcuhqy13x4q iw5
10 Aug 22
Shelf registration
8:35am
10-K
i6a81wvy sm
29 Mar 22
Annual report
7:21am
10-Q
pna0 4faj4svnen
8 Sep 21
Quarterly report
8:31am
424B4
vl0 ji40e9
30 Jul 21
Prospectus supplement with pricing info
4:06pm
S-1/A
bn71zcjfxu6
22 Jul 21
IPO registration (amended)
6:07am